PI3K/Akt-sensitive MEK-independent Compensatory Circuit of ERK Activation in ER-positive PI3K-mutant T47D Breast Cancer Cells

Cellular Signalling - United States
doi 10.1016/j.cellsig.2010.05.006
Full Text
Abstract

Available in full text

Categories
Cell Biology
Date
Authors
Publisher

Elsevier BV

Related search

Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2013English

ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

PLoS ONE
Multidisciplinary
2010English

Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

FOXP1 Regulation via the PI3K/Akt/p70S6K Signaling Pathway in Breast Cancer Cells

Oncology Letters
Cancer ResearchOncology
2015English

Downregulation of BAG‑1 in T47D Cells Promotes Resistance to Tamoxifen via Activation of the PI3K/Akt/mTOR Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2019English

Correlation Between Activation of PI3K/AKT/mTOR Pathway and Prognosis of Breast Cancer in Chinese Women

PLoS ONE
Multidisciplinary
2015English

Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Cancer Research
Cancer ResearchOncology
2011English

TrkB Promotes Laryngeal Cancer Metastasis via Activation PI3K/AKT Pathway

Oncotarget
Oncology
2017English

Fractalkine Stimulates Angiogenesis by Activating the Raf-1/Mek/Erk- And PI3K/Akt/eNOS-dependent Signal Pathways

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy